Inovio Pharmaceuticals
INO
#8805
Rank
S$0.19 B
Marketcap
S$2.89
Share price
-1.32%
Change (1 day)
19.17%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): S-$3.73

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S-$3.70. In 2024 the company made an earnings per share (EPS) of S-$5.08 an increase over its 2023 EPS that were of S-$7.83.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$3.73-26.58%
2024S-$5.08-35.14%
2023S-$7.83-56.62%
2022S-$18.04-19.54%
2021S-$22.4235.9%
2020S-$16.50-11.57%
2019S-$18.6615.24%
2018S-$16.19-2.78%
2017S-$16.656.93%
2016S-$15.57134.88%
2015S-$6.63-29.51%
2014S-$9.41-57.34%
2013S-$22.05146.55%
2012S-$8.9420.83%
2011S-$7.40-29.41%
2010S-$10.49-48.48%
2009S-$20.3510%
2008S-$18.5011.11%
2007S-$16.65-41.3%
2006S-$28.37-66.91%
2005S-$85.73110.61%
2004S-$40.71-61.63%
2003S-$106.09186.67%
2002S-$37.01
2001N/A-100%
2000S-$29.61-63.64%
1999S-$81.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$2.21-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$13.41-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S-$1.61-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.46-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$9.76-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$4.62-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
S$8.38-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA